Common use of Regulatory Materials; Data Clause in Contracts

Regulatory Materials; Data. Solely in the event of execution of, and in such event within […***…] days of the effective date of, the definitive license agreement entered into between the Parties with respect an Option exercised by ▇▇▇▇▇▇▇ as contemplated by this Section 10.5: (i) Poseida shall transfer and assign to ▇▇▇▇▇▇▇, as permitted by law, […***…] to ▇▇▇▇▇▇▇, all regulatory materials uniquely specific to any Centyrin CAR Molecule(s) and/or Centyrin Therapeutic Molecule(s) that is the subject of such license, all data from preclinical, non-clinical and clinical studies conducted by or on behalf of Poseida, its Affiliates or Sublicensees specific thereto and all pharmacovigilance data (including all adverse event databases) specific to such Centyrin CAR Molecule(s) and/or Centyrin Therapeutic Molecule(s); and (ii) At ▇▇▇▇▇▇▇’▇ request, Poseida shall provide ▇▇▇▇▇▇▇ with reasonable access to Poseida personnel and Poseida’s assistance with any inquiries and correspondence with Regulatory Authorities specific to the applicable such Centyrin CAR Molecule(s) and/or Centyrin Therapeutic Molecule(s), at a reasonable frequency, for a period of […***…] months thereafter.

Appears in 3 contracts

Sources: License Agreement (Poseida Therapeutics, Inc.), License Agreement (Poseida Therapeutics, Inc.), License Agreement (Poseida Therapeutics, Inc.)